Loss ofVav2Proto-Oncogene Causes Tachycardia and Cardiovascular Disease in Mice
- 1 March 2007
- journal article
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 18 (3) , 943-952
- https://doi.org/10.1091/mbc.e06-09-0877
Abstract
The Vav family is a group of signal transduction molecules that activate Rho/Rac GTPases during cell signaling. Experiments using knockout mice have indicated that the three Vav proteins present in mammals (Vav1, Vav2, and Vav3) are essential for proper signaling responses in hematopoietic cells. However, Vav2 and Vav3 are also highly expressed in nonhematopoietic tissues, suggesting that they may have additional functions outside blood cells. Here, we report that this is the case for Vav2, because the disruption of its locus in mice causes tachycardia, hypertension, and defects in the heart, arterial walls, and kidneys. We also provide physiological and pharmacological evidence demonstrating that the hypertensive condition of Vav2-deficient mice is due to a chronic stimulation of the renin/angiotensin II and sympathetic nervous systems. Together, these results indicate that Vav2 plays crucial roles in the maintenance of cardiovascular homeostasis in mice.Keywords
This publication has 25 references indexed in Scilit:
- Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunctionNature Medicine, 2006
- Impact of Increased Heart Rate on Clinical Outcomes in HypertensionDrugs, 2006
- The Rho/Rac-Family Guanine Nucleotide Exchange Factor VAV-1 Regulates Rhythmic Behaviors in C. elegansCell, 2005
- Phylogenetic conservation of the regulatory and functional properties of the Vav oncoprotein familyExperimental Cell Research, 2005
- Endoglin regulates nitric oxide‐dependent vasodilatationThe FASEB Journal, 2004
- Vav1/2/3-null Mice Define an Essential Role for Vav Family Proteins in Lymphocyte Development and Activation but a Differential Requirement in MAPK Signaling in T and B CellsThe Journal of Experimental Medicine, 2003
- VAV proteins as signal integrators for multi-subunit immune-recognition receptorsNature Reviews Immunology, 2002
- ABC of hypertension: The pathophysiology of hypertensionBMJ, 2001
- Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifsNature, 1992
- Product of vav proto-oncogene defines a new class of tyrosine protein kinase substratesNature, 1992